Literature DB >> 25468790

Diversity and disease pathogenesis in Mycobacterium tuberculosis.

Digby F Warner1, Anastasia Koch2, Valerie Mizrahi3.   

Abstract

The increasing availability of whole-genome sequence (WGS) data for Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB), suggests that circulating genotypes have been molded by three dominant evolutionary forces: long-term persistence within the human population, which requires a core programme of infection, disease, and transmission; selective pressure on specific genomic loci, which provides evidence of lineage-specific adaptation to host populations; and drug exposure, which has driven the rapid emergence of resistant isolates following the global implementation of anti-TB chemotherapy. Here, we provide an overview of these factors in considering the implications of genotypic diversity for disease pathogenesis, vaccine efficacy, and drug treatment.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mycobacterium tuberculosis; drugs; epistasis; evolution; genomics; mutagenesis; vaccine

Mesh:

Year:  2014        PMID: 25468790     DOI: 10.1016/j.tim.2014.10.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  18 in total

Review 1.  Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae.

Authors:  Ohad Gal-Mor
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

2.  Towards better prediction of Mycobacterium tuberculosis lineages from MIRU-VNTR data.

Authors:  Nithum Thain; Christopher Le; Aldo Crossa; Shama Desai Ahuja; Jeanne Sullivan Meissner; Barun Mathema; Barry Kreiswirth; Natalia Kurepina; Ted Cohen; Leonid Chindelevitch
Journal:  Infect Genet Evol       Date:  2018-06-28       Impact factor: 3.342

Review 3.  DNA Replication in Mycobacterium tuberculosis.

Authors:  Zanele Ditse; Meindert H Lamers; Digby F Warner
Journal:  Microbiol Spectr       Date:  2017-03

4.  The road to drug resistance in Mycobacterium tuberculosis.

Authors:  Anastasia Koch; Robert John Wilkinson
Journal:  Genome Biol       Date:  2014-11-13       Impact factor: 13.583

5.  High Sequence Variability of the ppE18 Gene of Clinical Mycobacterium tuberculosis Complex Strains Potentially Impacts Effectivity of Vaccine Candidate M72/AS01E.

Authors:  Susanne Homolka; Tanja Ubben; Stefan Niemann
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

6.  Identification of Quantitative Proteomic Differences between Mycobacterium tuberculosis Lineages with Altered Virulence.

Authors:  Julian S Peters; Bridget Calder; Giulia Gonnelli; Sven Degroeve; Elinambinina Rajaonarifara; Nicola Mulder; Nelson C Soares; Lennart Martens; Jonathan M Blackburn
Journal:  Front Microbiol       Date:  2016-05-31       Impact factor: 5.640

7.  Studies in the mouse model identify strain variability as a major determinant of disease outcome in Leishmania infantum infection.

Authors:  Filipe Marques; Sílvia Vale-Costa; Tânia Cruz; Joana Moreira Marques; Tânia Silva; João Vilares Neves; Sofia Cortes; Ana Fernandes; Eduardo Rocha; Rui Appelberg; Pedro Rodrigues; Ana M Tomás; Maria Salomé Gomes
Journal:  Parasit Vectors       Date:  2015-12-18       Impact factor: 3.876

8.  Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis.

Authors:  Fabien Le Chevalier; Alessandro Cascioferro; Wafa Frigui; Alexandre Pawlik; Eva C Boritsch; Daria Bottai; Laleh Majlessi; Jean Louis Herrmann; Roland Brosch
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

Review 9.  Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review.

Authors:  Hollie-Ann Hatherell; Caroline Colijn; Helen R Stagg; Charlotte Jackson; Joanne R Winter; Ibrahim Abubakar
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

Review 10.  Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.

Authors:  Leopold D Tientcheu; Anastasia Koch; Mthawelenga Ndengane; Genevieve Andoseh; Beate Kampmann; Robert J Wilkinson
Journal:  Eur J Immunol       Date:  2017-02-24       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.